Note Purchase AgreementNote Purchase Agreement • August 14th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Utah
Contract Type FiledAugust 14th, 2019 Company Industry JurisdictionThis Note Purchase Agreement (this “Agreement”), dated as of August 5, 2019, is entered into by and between Hemispherx Biopharma, Inc., a Delaware corporation (“Company”), and Chicago Venture Partners, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
Security AgreementSecurity Agreement • August 14th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Utah
Contract Type FiledAugust 14th, 2019 Company Industry JurisdictionThis Security Agreement (this “Agreement”), dated as of August 5, 2019, is executed by Hemispherx Biopharma, Inc., a Delaware corporation (“Debtor”), in favor of Chicago Venture Partners, L.P., a Utah limited partnership (“Secured Party”).